Search

Search results

1963 results found

Treatment-related harms: what was planned and what was reported? National Cancer Institute's Co-operative group phase III randomized controlled trials: a systematic review.

Mhaskar, Rahul S, Tea Reljic, Hesborn Wao, Ambuj Kumar, Branko Miladinovic, and Benjamin Djulbegovic. 2014. “Treatment-Related Harms: What Was Planned and What Was Reported? National Cancer Institute’s Co-Operative Group Phase III Randomized Controlled Trials: A Systematic Review.”. Journal of Clinical Epidemiology 67 (3): 354-6.

Role of high-dose chemotherapy and autologous hematopoietic cell transplantation in primary systemic amyloidosis: a systematic review.

Mhaskar, Rahul, Ambuj Kumar, Madhusmita Behera, Mohamed A Kharfan-Dabaja, and Benjamin Djulbegovic. 2009. “Role of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Primary Systemic Amyloidosis: A Systematic Review.”. Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 15 (8): 893-902.

ASTCT Committee on Practice Guidelines Survey on Evaluation and Management of Relapsed/Refractory Multiple Myeloma after Failure of Chimeric Antigen Receptor T Cell Therapy.

Hashmi, Hamza, Ambuj Kumar, Mohamed A Kharfan-Dabaja, Pashna N Munshi, Yoshihiro Inamoto, Zachariah DeFilipp, Bhagirathbhai Dholaria, et al. 2024. “ASTCT Committee on Practice Guidelines Survey on Evaluation and Management of Relapsed/Refractory Multiple Myeloma After Failure of Chimeric Antigen Receptor T Cell Therapy.”. Transplantation and Cellular Therapy.

Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.

Kharfan-Dabaja, Mohamed A, Ambuj Kumar, Mehdi Hamadani, Stephan Stilgenbauer, Paolo Ghia, Claudio Anasetti, Peter Dreger, et al. 2016. “Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.”. Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 22 (12): 2117-25.